![Bonnie Anderson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bonnie Anderson
Directeur/Bestuurslid bij
BRUKER CORPORATION
Vermogen: 802 019 $ op 30-06-2026
Profiel
Bonnie H.
Anderson was the founder of Veracyte, Inc., founded in 2008, where the title held was Chairman from 2021 to 2023.
Ms. Anderson is the founder of Pinkdx, Inc., founded in 2022, holding the titles of Chairman, President & Chief Executive Officer.
Current jobs include Independent Director at Bruker Corp.
since 2020, Director at Keck Graduate Institute of Applied Life Sciences, Independent Director at DNA Script SAS since 2021, and President at The Coalition for 21st Century Medicine.
Former jobs include Director & Vice President at Beckman Coulter, Inc. from 2000 to 2006, Director at Biotechnology Innovation Organization from 2015 to 2020, and Independent Director at Castle Biosciences, Inc. from 2015 to 2020.
Education includes an undergraduate degree from Indiana University of Pennsylvania conferred in 2012.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BRUKER CORPORATION 0,01% | 01-04-2026 | 13.327 ( 0,01% ) | 802 019 $ | 30-06-2026 |
Actieve functies van Bonnie Anderson
| Bedrijven | Functie | Begin |
|---|---|---|
| BRUKER CORPORATION | Directeur/Bestuurslid | 03-09-2020 |
Keck Graduate Institute of Applied Life Sciences
 Keck Graduate Institute of Applied Life Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Bestuurslid | - |
The Coalition for 21st Century Medicine
 The Coalition for 21st Century Medicine Miscellaneous Commercial ServicesCommercial Services The Coalition for 21st Century Medicine is a collaborative organization representing diagnostic technology companies, clinical laboratories, researchers, physicians, venture capitalists, and patient advocacy groups. The non-profit company is based in Arlington, VA. It is dedicated to advancing the development, commercialization, and adoption of molecular and genomic diagnostic technologies that enable personalized medicine, improve patient outcomes, and reduce healthcare costs. The coalition engages with policymakers to shape regulatory, reimbursement, and intellectual property policies supporting innovation in diagnostic medicine, advocates for balanced regulatory frameworks, opposes burdensome regulations on laboratory-developed tests, and promotes patent predictability. It addresses issues such as patent eligibility, Medicare payment modernization, and expanded coverage for advanced diagnostic assays, and regularly submits comments, position statements, and amicus briefs to protect intellectual property rights and improve patient access. The company was founded by Howard C. Birndorf, Jeffrey N. Peterson, M. Kathleen Behrens Wilsey, Patrick F. Terry. | President | - |
DNA Script SAS
 DNA Script SAS Miscellaneous Commercial ServicesCommercial Services Engages in R&D, produce single-stranded DNA sequence nucleotide chemistries and microbiology consumables | Directeur/Bestuurslid | 21-10-2021 |
Eerdere bekende functies van Bonnie Anderson
| Bedrijven | Functie | Einde |
|---|---|---|
| VERACYTE, INC. | Algemeen Directeur | 01-05-2021 |
| CASTLE BIOSCIENCES, INC. | Directeur/Bestuurslid | 16-08-2020 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Bestuurslid | 01-08-2020 |
Beckman Coulter, Inc.
 Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes biomedical testing instrument systems and general biomedical research products | Directeur/Bestuurslid | 01-03-2006 |
Opleiding van Bonnie Anderson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
64
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Beckman Coulter, Inc.
Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes biomedical testing instrument systems and general biomedical research products | Health Technology |
Bruker Corp.
 Bruker Corp. Medical SpecialtiesHealth Technology Manufactures analytical and medical instruments | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Veracyte, Inc.
 Veracyte, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes diagnostic products & biopharmaceutical services | Health Technology |
Castle Biosciences, Inc.
 Castle Biosciences, Inc. Medical SpecialtiesHealth Technology Operates dermatological cancer company which provides clinically actionable genomic information to make accurate treatment decisions | Health Technology |
Indiana University of Pennsylvania
 Indiana University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Keck Graduate Institute of Applied Life Sciences
Keck Graduate Institute of Applied Life Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Coalition for 21st Century Medicine
The Coalition for 21st Century Medicine Miscellaneous Commercial ServicesCommercial Services The Coalition for 21st Century Medicine is a collaborative organization representing diagnostic technology companies, clinical laboratories, researchers, physicians, venture capitalists, and patient advocacy groups. The non-profit company is based in Arlington, VA. It is dedicated to advancing the development, commercialization, and adoption of molecular and genomic diagnostic technologies that enable personalized medicine, improve patient outcomes, and reduce healthcare costs. The coalition engages with policymakers to shape regulatory, reimbursement, and intellectual property policies supporting innovation in diagnostic medicine, advocates for balanced regulatory frameworks, opposes burdensome regulations on laboratory-developed tests, and promotes patent predictability. It addresses issues such as patent eligibility, Medicare payment modernization, and expanded coverage for advanced diagnostic assays, and regularly submits comments, position statements, and amicus briefs to protect intellectual property rights and improve patient access. The company was founded by Howard C. Birndorf, Jeffrey N. Peterson, M. Kathleen Behrens Wilsey, Patrick F. Terry. | Commercial Services |
DNA Script SAS
DNA Script SAS Miscellaneous Commercial ServicesCommercial Services Engages in R&D, produce single-stranded DNA sequence nucleotide chemistries and microbiology consumables | Commercial Services |
